NIPT Test - Price, Purpose, Reports, Benefits, & More

Table of Content

Introduction to Non-Invasive Prenatal Testing

The NIPT test, or Non-Invasive Prenatal Testing, is offered during pregnancy to screen for the risk of certain chromosomal conditions in the baby, such as Down syndrome, Edwards syndrome, and Patau syndrome. It works by analysing tiny fragments of cell-free fetal DNA (cfDNA) that circulate in the pregnant person's blood — these fragments come from the placenta and carry information about the baby's genetic makeup. Because the sample is a simple blood draw, there's no needle anywhere near the uterus, which makes it a much gentler option than the older invasive tests.

NIPT is usually offered from around 10 weeks of pregnancy onward, earlier than most traditional screening approaches, and it's typically discussed alongside or instead of other options like the first-trimester combined screen, depending on what your doctor recommends and when you're screened. Your doctor might suggest NIPT if you're over 35, have a family history of chromosomal conditions, or had an earlier screening result come back unclear or concerning — though plenty of people choose it simply for the reassurance, regardless of risk factors.

One thing worth knowing from the outset, because it shapes how to read everything that follows: NIPT is a screening test, not a diagnostic one. It estimates risk; it doesn't confirm a diagnosis on its own. We'll come back to exactly what that means for your results a little further down.

You can book your NIPT test with Redcliffe Labs for reliable results at a fair price, with reports delivered on time and the option of a follow-up consultation to talk through what they mean.

Test Details in Brief

Why Consider the NIPT Test?

A few reasons this test has become a common part of prenatal care:

• Earlier, informed decision-making: because NIPT can be done from around 10 weeks, it gives you and your healthcare provider more time to plan next steps — whether that's further testing, additional monitoring, or simply peace of mind — than screening tests done later in pregnancy.
• Avoids unnecessary invasive testing: amniocentesis and chorionic villus sampling (CVS) both carry a small risk of complications, including miscarriage. NIPT gives many people a way to get meaningful information first, before deciding whether an invasive diagnostic test is actually needed.
• A strong detection rate for Down syndrome: cell-free DNA screening is commonly cited as detecting around 99% of Down syndrome cases, making it one of the most reliable screening options currently available. Detection rates for the other conditions it covers are generally good too, though they vary somewhat by condition — which is exactly why any higher-risk result gets followed up with a diagnostic test rather than treated as final.
• Works for most pregnancies: NIPT is offered to pregnant women broadly, not only those with known risk factors, including those of advanced maternal age (35 and older), a personal or family history of chromosomal conditions, or an abnormal ultrasound finding.

What Does the NIPT Test Screen For — and Not Screen For?

Chromosomal conditions happen when there's an extra or missing copy of a chromosome. The core panel screens for:

• Down syndrome (trisomy 21)
• Edwards syndrome (trisomy 18)
• Patau syndrome (trisomy 13)
• Turner syndrome (monosomy X) and Klinefelter syndrome (an extra X chromosome in males) — sex-chromosome conditions that expanded panels like this All Chromosome Test are able to screen for, alongside the three core trisomies above

The test can also reveal the baby's sex as a side finding, though that isn't its primary purpose. Occasionally it may flag something involving a less common chromosome, though accuracy for these rarer findings is less well established than for the conditions above.

It's just as useful to know what NIPT doesn't cover. It's built specifically to screen for chromosomal conditions — it doesn't screen for structural differences like congenital heart defects or neural tube defects, and it doesn't cover single-gene genetic conditions (things like cystic fibrosis or sickle cell disease, which need entirely different tests). A detailed anomaly ultrasound, usually done later in pregnancy, checks separately for many structural concerns. Your doctor can help map out which screening tests actually make sense for your pregnancy.

Understanding Your Results: Screening vs. Diagnosis

This is the part worth reading slowly, because it's easy to misread a screening result as more final than it actually is.

A low-risk result means the screening didn't find a pattern associated with an increased chance of the conditions tested. That's genuinely reassuring, and for most people, no further testing is needed. It doesn't guarantee a chromosomally typical baby in every single case — no screening test can promise that — but it meaningfully lowers the likelihood.

A high-risk result means the pattern detected is associated with a higher chance of that condition being present. It is not a diagnosis. False positives happen, and not always for reasons related to the baby at all — occasionally a result is influenced by factors on the placental or maternal side rather than the baby's own chromosomes. This is exactly why a high-risk NIPT result is always followed by a recommendation for diagnostic confirmation, usually amniocentesis or CVS, before any decisions get made.

If you do get a high-risk result, feeling frightened by it is a completely normal reaction, not an overreaction. It can help to remember that a screening result is a prompt to gather clearer information, not a final answer. Your doctor or a genetic counsellor can talk you through what your specific result means, what the confirmatory testing options involve, and what support is available — whatever you decide to do next.

One more thing worth knowing ahead of time: sometimes a sample simply doesn't contain enough fetal DNA to give a clear result. This is often called a "no-call" result, and it's more common very early in pregnancy or in a few other specific situations. It isn't a sign that anything is wrong with the pregnancy — it usually just means a repeat blood draw a little later will give the lab enough to work with.

Preparation for the NIPT Test

There's no special preparation needed — it's a simple blood draw, much like any other blood test you might have during pregnancy. A few things can make the experience smoother, though:

• Fasting: not required. Eat and drink normally beforehand.
• Ask your questions: don't hold back on anything you're wondering about — what the test covers, what a result might mean, or anything else on your mind.
• Consider genetic counselling beforehand too: if you have a family history of a genetic condition, or just want to think it through with someone before testing, a genetic counsellor can talk through what to expect either way the result comes back.

The Procedure for the NIPT Test

Your healthcare provider will draw the sample from a vein in your arm. The phlebotomist first cleans the site with an alcohol-based antiseptic, then inserts a small needle and gently draws a small amount of blood into a vial — you might feel a brief pinch, similar to any other blood test. Once the sample is collected, they'll cover the puncture site with a cotton gauze, then label the vial and send it for processing. The whole draw usually takes just a few minutes.

What Do the NIPT Test Reports Show?

Results are typically available within 10 days of sample collection. The report gives a risk assessment — "low risk" or "high risk" — for each chromosomal condition the test screens for, based on the patterns found in the cfDNA. For exactly what those two categories mean and what happens next, see Understanding Your Results above.

Who Should Take the NIPT Test?

NIPT is offered widely, but it's particularly often recommended for:

• Pregnant women older than 35
• Anyone with a personal or family history of a chromosomal condition
• Abnormal ultrasound findings
• Multiple gestations (twins or more) — though it's worth knowing that NIPT interpretation is somewhat more complex with more than one baby, and your doctor can walk you through what that means for your specific pregnancy

Plenty of people choose NIPT without any of these factors present too, often simply for the added reassurance. Talk to your doctor about whether it makes sense for your situation — and what its limits are, alongside its benefits.

NIPT Test Price at Redcliffe Labs

The NIPT test at Redcliffe Labs is priced at INR 12999. Home sample collection is available, so there's no need to travel to a lab during pregnancy. Our labs are NABL-accredited, meaning they follow defined quality and laboratory-practice standards, and reports are provided within the stated timeframe. You can also access your report online and arrange a free consultation to go through it, and other prenatal tests can be booked alongside NIPT if your doctor recommends them.

Note: We also offer the NIPT – All Chromosome Test PAN India. Call 898 898 8787 to check availability and pricing in your area.

Conclusion

The NIPT blood test screens for certain chromosomal conditions in a developing baby by analysing cell-free DNA circulating in the mother's blood — a mix of her own DNA and the baby's. It's become an increasingly common choice in prenatal care because it's non-invasive, has a strong detection rate for Down syndrome in particular, and can be done relatively early in pregnancy.

It isn't a diagnostic tool, though, and that distinction matters. A low-risk result is reassuring; a high-risk result is a prompt for further testing, not a final answer. Whatever your result shows, your doctor and a genetic counsellor, if you'd like one involved, are there to help you understand it and decide what, if anything, comes next.